目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Technology
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Technology outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Transcatheter Heart Valve Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of valvular heart diseases and aging population
3.2.1.2. Increasing preference for minimally invasive cardiac procedures
3.2.1.3. Technological advancements in valve design and delivery systems
3.2.2. Market restraint analysis
3.2.2.1. High procedural and device costs limiting accessibility
3.2.2.2. Complications related to valve durability and thrombosis risk
3.2.3. Market developments
3.2.3.1. Key clinical trials in the transcatheter heart valve market, by region
3.2.3.2. Recent product launches in the transcatheter heart valve market, by region
3.2.3.3. Emerging products in the transcatheter heart valve market, by region
3.2.4. Competitive factors and strategies
3.2.4.1. Clinical insights
3.2.4.2. Emerging technologies
3.2.4.3. Market appeal
3.2.4.4. Physician training and marketing
3.2.4.5. Product improvements and innovations
3.2.4.6. Mergers, acquisitions, and partnerships
3.2.4.7. Product portfolio management
3.3. Transcatheter Heart Valve Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Transcatheter Heart Valve Market: Application Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Application Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Transcatheter Aortic Valve
4.4.1. Transcatheter aortic valve market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Transcatheter Pulmonary Valve
4.5.1. Transcatheter pulmonary valve market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Transcatheter Mitral Valve
4.6.1. Transcatheter mitral valve market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Transcatheter Heart Valve Market: Technology Estimates & Trend Analysis
5.1. Definition and Scope
5.2. Application Market Share Analysis, 2024 & 2033
5.3. Segment Dashboard
5.4. Balloon Expanded Transcatheter Valve
5.4.1. Balloon expanded transcatheter valve market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Self-Expanded Transcatheter Valve
5.5.1. Self-expanded transcatheter valve market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Transcatheter Heart Valve Market: Regional Estimates & Trend Analysis by Application and Technology
6.1. Regional Dashboard
6.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
6.3. North America
6.3.1. U.S.
6.3.1.1. Key country dynamics
6.3.1.2. Regulatory framework/ reimbursement structure
6.3.1.3. Competitive scenario
6.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
6.3.2. Canada
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
6.3.3. Mexico
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
6.4.2. Germany
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
6.4.3. France
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
6.4.4. Italy
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
6.4.5. Spain
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
6.4.6. Norway
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
6.5.3. India
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
6.5.4. Australia
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
6.6.2. Argentina
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
6.7.3. UAE
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
6.7.4. Kuwait
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape
7.1. Company/Competition Categorization
7.2. Vendor Landscape
7.2.1. Key company market share analysis, 2024
7.2.2. Medtronic
7.2.2.1. Overview
7.2.2.2. Financial Performance
7.2.2.3. Product Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Abbott
7.2.3.1. Overview
7.2.3.2. Financial Performance
7.2.3.3. Product Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. Braile Biomédica
7.2.4.1. Overview
7.2.4.2. Financial Performance
7.2.4.3. Product Benchmarking
7.2.4.4. Strategic Initiatives
7.2.5. Meril Life Sciences Pvt. Ltd., Inc.
7.2.5.1. Overview
7.2.5.2. Financial Performance
7.2.5.3. Product Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Edwards Lifesciences Corporation
7.2.6.1. Overview
7.2.6.2. Financial Performance
7.2.6.3. Product Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. MicroPort Scientific Corporation
7.2.7.1. Overview
7.2.7.2. Financial Performance
7.2.7.3. Product Benchmarking
7.2.7.4. Strategic Initiatives
7.2.8. Venus Medtech (Hangzhou) Inc.
7.2.8.1. Overview
7.2.8.2. Financial Performance
7.2.8.3. Product Benchmarking
7.2.8.4. Strategic Initiatives
7.2.9. JenaValve
7.2.9.1. Overview
7.2.9.2. Financial Performance
7.2.9.3. Product Benchmarking
7.2.9.4. Strategic Initiatives
7.2.10. Biosensors International Group, Ltd
7.2.10.1. Overview
7.2.10.2. Financial Performance
7.2.10.3. Product Benchmarking
7.2.10.4. Strategic Initiatives
7.2.11. HLT Medical (Bracco)
7.2.11.1. Overview
7.2.11.2. Financial Performance
7.2.11.3. Product Benchmarking
7.2.11.4. Strategic Initiatives

List of Tables
Table 1 List of abbreviations
Table 2 North America transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
Table 3 North America transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 4 North America transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 5 U.S. transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 6 U.S. transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 7 Canada transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 8 Canada transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 9 Mexico transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 10 Mexico transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 11 Europe transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
Table 12 Europe transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 13 Europe transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 14 Germany transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 15 Germany transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 16 UK transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 17 UK transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 18 France transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 19 France transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 20 Italy transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 21 Italy transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 22 Spain transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 23 Spain transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 24 Denmark transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 25 Denmark transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 26 Sweden transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 27 Sweden transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 28 Norway transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 29 Norway transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 30 Asia Pacific transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
Table 31 Asia Pacific transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 32 Asia Pacific transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 33 China transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 34 China transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 35 Japan transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 36 Japan transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 37 India transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 38 India transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 39 South Korea transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 40 South Korea transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 41 Australia transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 42 Australia transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 43 Thailand transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 44 Thailand transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 45 Latin America transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
Table 46 Latin America transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 47 Latin America transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 48 Brazil transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 49 Brazil transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 50 Argentina transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 51 Argentina transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 52 MEA transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
Table 53 MEA transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 54 MEA transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 55 South Africa transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 56 South Africa transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 57 Saudi Arabia transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 58 Saudi Arabia transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 59 UAE transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 60 UAE transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
Table 61 Kuwait transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
Table 62 Kuwait transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Transcatheter heart valve market: outlook
Fig. 9 Transcatheter heart valve competitive insights
Fig. 10 Ancillary market outlook
Fig. 11 Transcatheter heart valve market driver impact
Fig. 12 Transcatheter heart valve market restraint impact
Fig. 13 Porter’s Analysis
Fig. 14 PESTLE Analysis
Fig. 15 Transcatheter heart valve market: Application movement analysis
Fig. 16 Transcatheter heart valve market: Application outlook and key takeaways
Fig. 17 Transcatheter aortic valve market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 18 Transcatheter pulmonary valve market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 19 Transcatheter mitral valve market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 20 Transcatheter heart valve market: Technology movement analysis
Fig. 21 Transcatheter heart valve market: Technology outlook and key takeaways
Fig. 22 Balloon expanded transcatheter valve market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 23 Self-expanded transcatheter valve market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 24 Global transcatheter heart valve market: Regional movement analysis
Fig. 25 Global transcatheter heart valve market: Regional outlook and key takeaways
Fig. 26 North America, by country
Fig. 27 North America market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 U.S. key country dynamics
Fig. 29 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Canada key country dynamics
Fig. 31 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Mexico key country dynamics
Fig. 33 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 UK key country dynamics
Fig. 36 UK market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Germany key country dynamics
Fig. 38 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 France key country dynamics
Fig. 40 France market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Italy key country dynamics
Fig. 42 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Spain key country dynamics
Fig. 44 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 Denmark key country dynamics
Fig. 46 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Sweden key country dynamics
Fig. 48 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Norway key country dynamics
Fig. 50 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 China key country dynamics
Fig. 53 China market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 Japan key country dynamics
Fig. 55 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 56 India key country dynamics
Fig. 57 India market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 Thailand key country dynamics
Fig. 59 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 South Korea key country dynamics
Fig. 61 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 62 Australia key country dynamics
Fig. 63 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 65 Brazil key country dynamics
Fig. 66 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 67 Argentina key country dynamics
Fig. 68 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 69 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 70 South Africa key country dynamics
Fig. 71 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 72 Saudi Arabia key country dynamics
Fig. 73 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 74 UAE key country dynamics
Fig. 75 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 76 Kuwait key country dynamics
Fig. 77 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 78 Key company categorization
Fig. 79 Heat map analysis 2024